TreeWAS – Variant ID: rs7604423

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E20-E35 Disorders of other endocrine glands	0.679	0.321	0.000
Chapter IV Endocrine, nutritional and metabolic diseases	0.671	0.329	0.000
E00-E07 Disorders of thyroid gland	0.671	0.329	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.667	0.333	0.000
E05.9 Thyrotoxicosis, unspecified	0.661	0.339	0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion	0.661	0.339	0.000
E16.2 Hypoglycaemia, unspecified	0.658	0.342	0.000
E16 Other disorders of pancreatic internal secretion	0.655	0.345	0.000
E23 Hypofunction and other disorders of pituitary gland	0.647	0.353	0.000
E27 Other disorders of adrenal gland	0.638	0.362	0.000
E04 Other non-toxic goitre	0.634	0.366	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.627	0.373	0.000
E40-E46 Malnutrition	0.603	0.397	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.601	0.399	0.000
E04.2 Non-toxic multinodular goitre	0.590	0.410	0.000
E22 Hyperfunction of pituitary gland	0.588	0.412	0.000
E21.3 Hyperparathyroidism, unspecified	0.579	0.421	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.575	0.425	0.000
E34 Other endocrine disorders	0.573	0.427	0.000
E23.0 Hypopituitarism	0.570	0.429	0.000
E23.7 Disorder of pituitary gland, unspecified	0.563	0.437	0.000
E29 Testicular dysfunction	0.561	0.439	0.000
E04.9 Non-toxic goitre, unspecified	0.556	0.444	0.000
E46 Unspecified protein-energy malnutrition	0.553	0.447	0.000
E23.2 Diabetes insipidus	0.552	0.448	0.000
E24 Cushing's syndrome	0.549	0.451	0.000
E04.0 Non-toxic diffuse goitre	0.537	0.463	0.000
E07 Other disorders of thyroid	0.537	0.463	0.000
E06 Thyroiditis	0.531	0.469	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.530	0.470	0.000
E20 Hypoparathyroidism	0.527	0.473	0.000
E34.9 Endocrine disorder, unspecified	0.506	0.494	0.000
E32 Diseases of thymus	0.502	0.498	0.000
E29.1 Testicular hypofunction	0.494	0.506	0.000
E22.1 Hyperprolactinaemia	0.492	0.508	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.487	0.513	0.000
E30 Disorders of puberty, not elsewhere classified	0.487	0.513	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.481	0.519	0.000
E00 Congenital iodine-deficiency syndrome	0.481	0.519	0.000
E05.5 Thyroid crisis or storm	0.478	0.521	0.000
E05.4 Thyrotoxicosis factitia	0.478	0.521	0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.478	0.521	0.000
E06.3 Autoimmune thyroiditis	0.476	0.524	0.000
E22.0 Acromegaly and pituitary gigantism	0.476	0.524	0.000
E27.3 Drug-induced adrenocortical insufficiency	0.475	0.525	0.000
E15 Nondiabetic hypoglycaemic coma	0.474	0.526	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.469	0.531	0.000
E16.8 Other specified disorders of pancreatic internal secretion	0.469	0.531	0.000
E16.4 Abnormal secretion of gastrin	0.469	0.531	0.000
E16.3 Increased secretion of glucagon	0.469	0.531	0.000
E27.2 Addisonian crisis	0.468	0.532	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.467	0.533	0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified	0.466	0.534	0.000
E23.1 Drug-induced hypopituitarism	0.464	0.536	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.464	0.536	0.000
E25 Adrenogenital disorders	0.464	0.536	0.000
E27.5 Adrenomedullary hyperfunction	0.458	0.542	0.000
E27.0 Other adrenocortical overactivity	0.458	0.542	0.000
E31 Polyglandular dysfunction	0.456	0.543	0.000
E04.8 Other specified non-toxic goitre	0.455	0.545	0.000
E50-E64 Other nutritional deficiencies	0.452	0.548	0.000
E44 Protein-energy malnutrition of moderate and mild degree	0.432	0.568	0.000
E45 Retarded development following protein-energy malnutrition	0.432	0.568	0.000
E43 Unspecified severe protein-energy malnutrition	0.432	0.568	0.000
E42 Marasmic kwashiorkor	0.432	0.568	0.000
E41 Nutritional marasmus	0.432	0.568	0.000
E40 Kwashiorkor	0.432	0.568	0.000
E24.9 Cushing's syndrome, unspecified	0.431	0.569	0.000
E07.9 Disorder of thyroid, unspecified	0.429	0.571	0.000
E24.8 Other Cushing's syndrome	0.426	0.574	0.000
E22.9 Hyperfunction of pituitary gland, unspecified	0.422	0.578	0.000
E22.8 Other hyperfunction of pituitary gland	0.422	0.578	0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone	0.421	0.579	0.000
E21.2 Other hyperparathyroidism	0.417	0.583	0.000
E16.1 Other hypoglycaemia	0.416	0.583	0.000
E34.3 Short stature, not elsewhere classified	0.413	0.586	0.000
E23.6 Other disorders of pituitary gland	0.412	0.588	0.000
E34.5 Androgen resistance syndrome	0.411	0.589	0.000
E34.4 Constitutional tall stature	0.411	0.589	0.000
E34.2 Ectopic hormone secretion, not elsewhere classified	0.411	0.589	0.000
E34.1 Other hypersecretion of intestinal hormones	0.411	0.589	0.000
E20.1 Pseudohypoparathyroidism	0.408	0.592	0.000
E34.0 Carcinoid syndrome	0.404	0.596	0.000
E29.8 Other testicular dysfunction	0.402	0.598	0.000
E29.0 Testicular hyperfunction	0.402	0.598	0.000
E07.8 Other specified disorders of thyroid	0.401	0.599	0.000
E24.0 Pituitary-dependent Cushing's disease	0.398	0.602	0.000
E34.8 Other specified endocrine disorders	0.398	0.602	0.000
E05.8 Other thyrotoxicosis	0.394	0.605	0.000
E27.1 Primary adrenocortical insufficiency	0.394	0.605	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.393	0.606	0.000
E24.3 Ectopic ACTH syndrome	0.393	0.606	0.000
E24.1 Nelson's syndrome	0.393	0.606	0.000
E21.4 Other specified disorders of parathyroid gland	0.392	0.608	0.000
E20.9 Hypoparathyroidism, unspecified	0.389	0.611	0.000
E24.2 Drug-induced Cushing's syndrome	0.387	0.613	0.000
E27.9 Disorder of adrenal gland, unspecified	0.386	0.614	0.000
E07.1 Dyshormogenetic goitre	0.385	0.615	0.000
E07.0 Hypersecretion of calcitonin	0.385	0.615	0.000
E21.5 Disorder of parathyroid gland, unspecified	0.383	0.617	0.000
E06.4 Drug-induced thyroiditis	0.381	0.619	0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.381	0.619	0.000
E06.0 Acute thyroiditis	0.381	0.619	0.000
E20.8 Other hypoparathyroidism	0.379	0.621	0.000
E20.0 Idiopathic hypoparathyroidism	0.378	0.622	0.000
E32.9 Disease of thymus, unspecified	0.375	0.625	0.000
E27.8 Other specified disorders of adrenal gland	0.375	0.625	0.000
E06.5 Other chronic thyroiditis	0.367	0.632	0.000
E26 Hyperaldosteronism	0.363	0.637	0.000
E06.1 Subacute thyroiditis	0.362	0.638	0.000
E54 Ascorbic acid deficiency	0.362	0.638	0.000
E32.8 Other diseases of thymus	0.360	0.640	0.000
E32.1 Abscess of thymus	0.360	0.640	0.000
E32.0 Persistent hyperplasia of thymus	0.360	0.640	0.000
E29.9 Testicular dysfunction, unspecified	0.360	0.640	0.000
E61 Deficiency of other nutrient elements	0.351	0.649	0.000
E30.9 Disorder of puberty, unspecified	0.349	0.651	0.000
E30.8 Other disorders of puberty	0.349	0.651	0.000
E30.1 Precocious puberty	0.349	0.651	0.000
E30.0 Delayed puberty	0.349	0.651	0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere	0.349	0.651	0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere	0.349	0.651	0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere	0.349	0.651	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.345	0.655	0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.345	0.655	0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.345	0.655	0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.345	0.655	0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.345	0.655	0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.345	0.655	0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.345	0.655	0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.345	0.655	0.000
E51 Thiamine deficiency	0.333	0.667	0.000
E25.9 Adrenogenital disorder, unspecified	0.332	0.667	0.000
E25.8 Other adrenogenital disorders	0.332	0.667	0.000
E31.9 Polyglandular dysfunction, unspecified	0.327	0.672	0.000
E31.8 Other polyglandular dysfunction	0.327	0.672	0.000
E31.1 Polyglandular hyperfunction	0.327	0.672	0.000
E58 Dietary calcium deficiency	0.327	0.673	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.327	0.673	0.001
E64 Sequelae of malnutrition and other nutritional deficiencies	0.324	0.676	0.000
E50 Vitamin A deficiency	0.324	0.676	0.000
E60 Dietary zinc deficiency	0.324	0.676	0.000
E59 Dietary selenium deficiency	0.324	0.676	0.000
E52 Niacin deficiency [pellagra]	0.324	0.676	0.000
E65-E68 Obesity and other hyperalimentation	0.323	0.677	0.000
E55 Vitamin D deficiency	0.314	0.685	0.000
E56 Other vitamin deficiencies	0.313	0.687	0.000
E63 Other nutritional deficiencies	0.312	0.688	0.000
E44.1 Mild protein-energy malnutrition	0.310	0.690	0.000
E44.0 Moderate protein-energy malnutrition	0.310	0.690	0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency	0.309	0.691	0.000
E06.9 Thyroiditis, unspecified	0.307	0.692	0.000
E21.0 Primary hyperparathyroidism	0.306	0.694	0.000
E28 Ovarian dysfunction	0.303	0.697	0.000
E16.0 Drug-induced hypoglycaemia without coma	0.301	0.699	0.001
E31.0 Autoimmune polyglandular failure	0.297	0.703	0.000
E61.1 Iron deficiency	0.288	0.712	0.000
E26.8 Other hyperaldosteronism	0.260	0.739	0.000
E26.1 Secondary hyperaldosteronism	0.260	0.739	0.000
E61.9 Deficiency of nutrient element, unspecified	0.251	0.748	0.000
E61.8 Deficiency of other specified nutrient elements	0.251	0.748	0.000
E61.7 Deficiency of multiple nutrient elements	0.251	0.748	0.000
E61.6 Vanadium deficiency	0.251	0.748	0.000
E61.5 Molybdenum deficiency	0.251	0.748	0.000
E61.4 Chromium deficiency	0.251	0.748	0.000
E61.3 Manganese deficiency	0.251	0.748	0.000
E61.0 Copper deficiency	0.251	0.748	0.000
E51.2 Wernicke's encephalopathy	0.247	0.753	0.000
E51.9 Thiamine deficiency, unspecified	0.238	0.761	0.000
E51.8 Other manifestations of thiamine deficiency	0.238	0.761	0.000
E51.1 Beriberi	0.238	0.761	0.000
E61.2 Magnesium deficiency	0.237	0.763	0.000
E50.9 Vitamin A deficiency, unspecified	0.232	0.767	0.000
E50.8 Other manifestations of vitamin A deficiency	0.232	0.767	0.000
E50.7 Other ocular manifestations of vitamin A deficiency	0.232	0.767	0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea	0.232	0.767	0.000
E50.5 Vitamin A deficiency with night blindness	0.232	0.767	0.000
E50.4 Vitamin A deficiency with keratomalacia	0.232	0.767	0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis	0.232	0.767	0.000
E50.2 Vitamin A deficiency with corneal xerosis	0.232	0.767	0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis	0.232	0.767	0.000
E50.0 Vitamin A deficiency with conjunctival xerosis	0.232	0.767	0.000
E64.9 Sequelae of unspecified nutritional deficiency	0.232	0.767	0.000
E64.8 Sequelae of other nutritional deficiencies	0.232	0.767	0.000
E64.3 Sequelae of rickets	0.232	0.767	0.000
E64.2 Sequelae of vitamin C deficiency	0.232	0.767	0.000
E64.1 Sequelae of vitamin A deficiency	0.232	0.767	0.000
E64.0 Sequelae of protein-energy malnutrition	0.232	0.767	0.000
E67 Other hyperalimentation	0.232	0.768	0.000
E68 Sequelae of hyperalimentation	0.232	0.768	0.000
E65 Localised adiposity	0.232	0.768	0.000
E55.0 Rickets, active	0.226	0.774	0.000
E56.9 Vitamin deficiency, unspecified	0.224	0.776	0.000
E56.8 Deficiency of other vitamins	0.224	0.776	0.000
E56.0 Deficiency of vitamin E	0.224	0.776	0.000
E63.8 Other specified nutritional deficiencies	0.224	0.776	0.000
E63.1 Imbalance of constituents of food intake	0.224	0.776	0.000
E63.0 Essential fatty acid [EFA] deficiency	0.224	0.776	0.000
E26.9 Hyperaldosteronism, unspecified	0.219	0.780	0.000
E28.9 Ovarian dysfunction, unspecified	0.217	0.782	0.000
E28.8 Other ovarian dysfunction	0.217	0.782	0.000
E28.1 Androgen excess	0.217	0.782	0.000
E28.0 Oestrogen excess	0.217	0.782	0.000
E55.9 Vitamin D deficiency, unspecified	0.216	0.784	0.000
E56.1 Deficiency of vitamin K	0.213	0.787	0.000
E63.9 Nutritional deficiency, unspecified	0.212	0.788	0.000
E53 Deficiency of other B group vitamins	0.207	0.793	0.001
E26.0 Primary hyperaldosteronism	0.201	0.798	0.000
E04.1 Non-toxic single thyroid nodule	0.191	0.809	0.000
E28.3 Primary ovarian failure	0.168	0.832	0.000
E67.8 Other specified hyperalimentation	0.166	0.833	0.000
E67.3 Hypervitaminosis D	0.166	0.833	0.000
E67.2 Megavitamin-B6 syndrome	0.166	0.833	0.000
E67.1 Hypercarotenaemia	0.166	0.833	0.000
E67.0 Hypervitaminosis A	0.166	0.833	0.000
E03 Other hypothyroidism	0.164	0.836	0.000
E53.9 Vitamin B deficiency, unspecified	0.155	0.844	0.001
E53.1 Pyridoxine deficiency	0.148	0.851	0.001
E53.0 Riboflavin deficiency	0.148	0.851	0.001
E28.2 Polycystic ovarian syndrome	0.132	0.868	0.000
E03.0 Congenital hypothyroidism with diffuse goitre	0.120	0.880	0.000
E03.5 Myxoedema coma	0.118	0.882	0.000
E03.4 Atrophy of thyroid (acquired)	0.118	0.882	0.000
E03.3 Postinfectious hypothyroidism	0.118	0.882	0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.115	0.885	0.000
E03.8 Other specified hypothyroidism	0.102	0.898	0.000
E03.1 Congenital hypothyroidism without goitre	0.087	0.913	0.000
E66 Obesity	0.074	0.926	0.000
E10-E14 Diabetes mellitus	0.062	0.937	0.000
E66.2 Extreme obesity with alveolar hypoventilation	0.059	0.941	0.000
E66.1 Drug-induced obesity	0.053	0.947	0.000
E66.0 Obesity due to excess calories	0.053	0.947	0.000
E12 Malnutrition-related diabetes mellitus	0.045	0.955	0.000
E13 Other specified diabetes mellitus	0.040	0.960	0.000
E70-E90 Metabolic disorders	0.040	0.960	0.000
E85 Amyloidosis	0.040	0.960	0.000
E85.4 Organ-limited amyloidosis	0.036	0.964	0.000
E74 Other disorders of carbohydrate metabolism	0.036	0.964	0.000
E11.2 With renal complications	0.035	0.965	0.000
E85.9 Amyloidosis, unspecified	0.035	0.965	0.000
E11 Non-insulin-dependent diabetes mellitus	0.034	0.966	0.000
E74.3 Other disorders of intestinal carbohydrate absorption	0.033	0.967	0.000
E89 Postprocedural endocrine and metabolic disorders, not elsewhere classified	0.033	0.967	0.000
E12.9 Without complications	0.032	0.967	0.000
E12.8 With unspecified complications	0.032	0.967	0.000
E12.7 With multiple complications	0.032	0.967	0.000
E12.6 With other specified complications	0.032	0.967	0.000
E12.5 With peripheral circulatory complications	0.032	0.967	0.000
E12.4 With neurological complications	0.032	0.967	0.000
E12.3 With ophthalmic complications	0.032	0.967	0.000
E12.2 With renal complications	0.032	0.967	0.000
E12.1 With ketoacidosis	0.032	0.967	0.000
E12.0 With coma	0.032	0.967	0.000
E85.3 Secondary systemic amyloidosis	0.031	0.968	0.000
E85.8 Other amyloidosis	0.029	0.971	0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.029	0.971	0.000
E13.8 With unspecified complications	0.029	0.971	0.000
E13.7 With multiple complications	0.029	0.971	0.000
E13.6 With other specified complications	0.029	0.971	0.000
E13.5 With peripheral circulatory complications	0.029	0.971	0.000
E13.4 With neurological complications	0.029	0.971	0.000
E13.2 With renal complications	0.029	0.971	0.000
E13.1 With ketoacidosis	0.029	0.971	0.000
E13.0 With coma	0.029	0.971	0.000
E77 Disorders of glycoprotein metabolism	0.029	0.971	0.000
E76 Disorders of glycosaminoglycan metabolism	0.029	0.971	0.000
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.029	0.971	0.000
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.029	0.971	0.000
E72 Other disorders of amino-acid metabolism	0.029	0.971	0.000
E85.2 Heredofamilial amyloidosis, unspecified	0.028	0.971	0.000
E85.1 Neuropathic heredofamilial amyloidosis	0.028	0.971	0.000
E85.0 Nonneuropathic heredofamilial amyloidosis	0.028	0.971	0.000
E11.0 With coma	0.028	0.972	0.000
E11.6 With other specified complications	0.028	0.972	0.000
E11.4 With neurological complications	0.028	0.972	0.000
E89.3 Postprocedural hypopituitarism	0.027	0.972	0.000
E74.0 Glycogen storage disease	0.027	0.973	0.000
E13.9 Without complications	0.027	0.973	0.000
E70 Disorders of aromatic amino-acid metabolism	0.027	0.973	0.000
E74.9 Disorder of carbohydrate metabolism, unspecified	0.026	0.974	0.000
E74.8 Other specified disorders of carbohydrate metabolism	0.026	0.974	0.000
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.026	0.974	0.000
E74.2 Disorders of galactose metabolism	0.026	0.974	0.000
E74.1 Disorders of fructose metabolism	0.026	0.974	0.000
E84 Cystic fibrosis	0.026	0.974	0.000
E73 Lactose intolerance	0.026	0.974	0.000
E89.4 Postprocedural ovarian failure	0.026	0.974	0.000
E13.3 With ophthalmic complications	0.025	0.974	0.000
E89.0 Postprocedural hypothyroidism	0.025	0.975	0.000
E89.5 Postprocedural testicular hypofunction	0.025	0.975	0.000
E89.6 Postprocedural adrenocortical(-medullary) hypofunction	0.025	0.975	0.000
E79 Disorders of purine and pyrimidine metabolism	0.024	0.976	0.000
E11.7 With multiple complications	0.024	0.976	0.000
E89.9 Postprocedural endocrine and metabolic disorder, unspecified	0.024	0.976	0.000
E89.8 Other postprocedural endocrine and metabolic disorders	0.024	0.976	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.021	0.978	0.000
E75.5 Other lipid storage disorders	0.021	0.979	0.000
E75.6 Lipid storage disorder, unspecified	0.021	0.979	0.000
E75.4 Neuronal ceroid lipofuscinosis	0.021	0.979	0.000
E75.3 Sphingolipidosis, unspecified	0.021	0.979	0.000
E75.2 Other sphingolipidosis	0.021	0.979	0.000
E75.1 Other gangliosidosis	0.021	0.979	0.000
E75.0 GM2 gangliosidosis	0.021	0.979	0.000
E71.3 Disorders of fatty-acid metabolism	0.021	0.979	0.000
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.021	0.979	0.000
E71.1 Other disorders of branched-chain amino-acid metabolism	0.021	0.979	0.000
E71.0 Maple-syrup-urine disease	0.021	0.979	0.000
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.021	0.979	0.000
E76.8 Other disorders of glucosaminoglycan metabolism	0.021	0.979	0.000
E76.3 Mucopolysaccharidosis, unspecified	0.021	0.979	0.000
E76.2 Other mucopolysaccharidoses	0.021	0.979	0.000
E76.1 Mucopolysaccharidosis, type II	0.021	0.979	0.000
E76.0 Mucopolysaccharidosis, type I	0.021	0.979	0.000
E77.9 Disorder of glycoprotein metabolism, unspecified	0.021	0.979	0.000
E77.8 Other disorders of glycoprotein metabolism	0.021	0.979	0.000
E77.1 Defects in glycoprotein degradation	0.021	0.979	0.000
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.021	0.979	0.000
E72.9 Disorder of amino-acid metabolism, unspecified	0.021	0.979	0.000
E72.8 Other specified disorders of amino-acid metabolism	0.021	0.979	0.000
E72.5 Disorders of glycine metabolism	0.021	0.979	0.000
E72.4 Disorders of ornithine metabolism	0.021	0.979	0.000
E72.3 Disorders of lysine and hydroxylysine metabolism	0.021	0.979	0.000
E72.2 Disorders of urea cycle metabolism	0.021	0.979	0.000
E72.0 Disorders of amino-acid transport	0.020	0.980	0.000
E89.1 Postprocedural hypoinsulinaemia	0.019	0.980	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.019	0.980	0.000
E70.8 Other disorders of aromatic amino-acid metabolism	0.019	0.980	0.000
E70.2 Disorders of tyrosine metabolism	0.019	0.980	0.000
E70.1 Other hyperphenylalaninaemias	0.019	0.980	0.000
E70.0 Classical phenylketonuria	0.019	0.980	0.000
E88 Other metabolic disorders	0.019	0.981	0.000
E84.8 Cystic fibrosis with other manifestations	0.019	0.981	0.000
E84.1 Cystic fibrosis with intestinal manifestations	0.019	0.981	0.000
E73.8 Other lactose intolerance	0.019	0.981	0.000
E73.1 Secondary lactase deficiency	0.019	0.981	0.000
E73.0 Congenital lactase deficiency	0.019	0.981	0.000
E89.2 Postprocedural hypoparathyroidism	0.018	0.982	0.000
E84.0 Cystic fibrosis with pulmonary manifestations	0.018	0.982	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.018	0.982	0.000
E79.8 Other disorders of purine and pyrimidine metabolism	0.018	0.982	0.000
E79.1 Lesch-Nyhan syndrome	0.018	0.982	0.000
E70.3 Albinism	0.017	0.983	0.000
E84.9 Cystic fibrosis, unspecified	0.017	0.983	0.000
N18.9 Chronic renal failure, unspecified	0.016	0.984	0.000
N18.5 Chronic kidney disease, stage 5	0.016	0.984	0.000
N18 Chronic renal failure	0.016	0.984	0.000
E73.9 Lactose intolerance, unspecified	0.016	0.984	0.000
E88.3 Tumour lysis syndrome	0.015	0.985	0.000
E88.1 Lipodystrophy, not elsewhere classified	0.014	0.986	0.000
N18.0 End-stage renal disease	0.014	0.986	0.000
N18.4 Chronic kidney disease, stage 4	0.014	0.986	0.000
E80 Disorders of porphyrin and bilirubin metabolism	0.014	0.986	0.000
E88.9 Metabolic disorder, unspecified	0.014	0.986	0.000
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.013	0.987	0.000
J06.9 Acute upper respiratory infection, unspecified	0.000	0.987	0.013
E88.8 Other specified metabolic disorders	0.013	0.987	0.000
E11.8 With unspecified complications	0.013	0.987	0.000
N18.2 Chronic kidney disease, stage 2	0.013	0.987	0.000
N18.1 Chronic kidney disease, stage 1	0.013	0.987	0.000
E11.1 With ketoacidosis	0.013	0.987	0.000
Z49.0 Preparatory care for dialysis	0.012	0.988	0.000
N03.9 Unspecified	0.012	0.988	0.000
E11.5 With peripheral circulatory complications	0.012	0.988	0.000
E88.2 Lipomatosis, not elsewhere classified	0.011	0.988	0.000
K52.8 Other specified non-infective gastro-enteritis and colitis	0.011	0.989	0.000
Z49.1 Extracorporeal dialysis	0.011	0.989	0.000
E80.1 Porphyria cutanea tarda	0.010	0.990	0.000
E80.5 Crigler-Najjar syndrome	0.010	0.990	0.000
E80.3 Defects of catalase and peroxydase	0.010	0.990	0.000
E80.0 Hereditary erythropoietic porphyria	0.010	0.990	0.000
N18.8 Other chronic renal failure	0.010	0.990	0.000
Z49 Care involving dialysis	0.010	0.990	0.000
E80.7 Disorder of bilirubin metabolism, unspecified	0.010	0.990	0.000
E11.3 With ophthalmic complications	0.010	0.990	0.000
E80.2 Other porphyria	0.009	0.990	0.000
E53.8 Deficiency of other specified B group vitamins	0.007	0.990	0.003
O26.9 Pregnancy-related condition, unspecified	0.000	0.991	0.009
O26 Maternal care for other conditions predominantly related to pregnancy	0.000	0.991	0.009
E83 Disorders of mineral metabolism	0.008	0.992	0.000
Q51.3 Bicornate uterus	0.008	0.992	0.000
R73.9 Hyperglycaemia, unspecified	0.000	0.992	0.008
O26.2 Pregnancy care of habitual aborter	0.000	0.992	0.008
Z49.2 Other dialysis	0.008	0.992	0.000
O20-O29 Other maternal disorders predominantly related to pregnancy	0.000	0.992	0.008
N03 Chronic nephritic syndrome	0.008	0.992	0.000
O21 Excessive vomiting in pregnancy	0.000	0.992	0.008
O26.0 Excessive weight gain in pregnancy	0.000	0.993	0.007
A08.4 Viral intestinal infection, unspecified	0.000	0.993	0.007
O26.7 Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium	0.000	0.993	0.007
O21.0 Mild hyperemesis gravidarum	0.000	0.993	0.007
E80.6 Other disorders of bilirubin metabolism	0.007	0.993	0.001
E88.0 Disorders of plasma-protein metabolism, not elsewhere classified	0.007	0.993	0.000
M49.54 Collapsed vertebra in diseases classified elsewhere (Thoracic region)	0.000	0.993	0.007
O26.3 Retained intra-uterine contraceptive device in pregnancy	0.000	0.993	0.007
O26.6 Liver disorders in pregnancy, childbirth and the puerperium	0.000	0.993	0.007
O26.5 Maternal hypotension syndrome	0.000	0.993	0.006
O26.4 Herpes gestationis	0.000	0.993	0.006
O26.1 Low weight gain in pregnancy	0.000	0.993	0.006
O23 Infections of genito-urinary tract in pregnancy	0.000	0.994	0.006
O21.9 Vomiting of pregnancy, unspecified	0.000	0.994	0.006
E83.8 Other disorders of mineral metabolism	0.006	0.994	0.000
E83.2 Disorders of zinc metabolism	0.006	0.994	0.000
E83.0 Disorders of copper metabolism	0.006	0.994	0.000
R00.8 Other and unspecified abnormalities of heart beat	0.000	0.994	0.006
O21.1 Hyperemesis gravidarum with metabolic disturbance	0.000	0.994	0.006
N03.5 Diffuse mesangiocapillary glomerulonephritis	0.006	0.994	0.000
O28 Abnormal findings on antenatal screening of mother	0.000	0.994	0.006
O20 Haemorrhage in early pregnancy	0.000	0.994	0.006
E83.9 Disorder of mineral metabolism, unspecified	0.006	0.994	0.000
O20.8 Other haemorrhage in early pregnancy	0.000	0.994	0.006
N03.8 Other	0.006	0.994	0.000
E83.1 Disorders of iron metabolism	0.006	0.994	0.000
O22 Venous complications in pregnancy	0.000	0.994	0.006
O29 Complications of anaesthesia during pregnancy	0.000	0.994	0.006
O25 Malnutrition in pregnancy	0.000	0.994	0.006
N03.7 Diffuse crescentic glomerulonephritis	0.006	0.994	0.000
N03.6 Dense deposit disease	0.006	0.994	0.000
N03.4 Diffuse endocapillary proliferative glomerulonephritis	0.006	0.994	0.000
N03.3 Diffuse mesangial proliferative glomerulonephritis	0.006	0.994	0.000
N03.0 Minor glomerular abnormality	0.006	0.994	0.000
O24 Diabetes mellitus in pregnancy	0.000	0.994	0.006
N03.1 Focal and segmental glomerular lesions	0.006	0.994	0.000
O21.2 Late vomiting of pregnancy	0.000	0.994	0.005
N03.2 Diffuse membranous glomerulonephritis	0.005	0.994	0.000
O28.1 Abnormal biochemical finding on antenatal screening of mother	0.000	0.994	0.005
J06 Acute upper respiratory infections of multiple and unspecified sites	0.000	0.994	0.005
H43.8 Other disorders of vitreous body	0.000	0.995	0.005
O23.5 Infections of the genital tract in pregnancy	0.000	0.995	0.005
O23.4 Unspecified infection of urinary tract in pregnancy	0.000	0.995	0.005
R73 Elevated blood glucose level	0.000	0.995	0.005
E80.4 Gilbert's syndrome	0.005	0.995	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.005	0.995	0.000
O20.9 Haemorrhage in early pregnancy, unspecified	0.000	0.995	0.005
O23.0 Infections of kidney in pregnancy	0.000	0.995	0.005
E83.4 Disorders of magnesium metabolism	0.005	0.995	0.000
R73.0 Abnormal glucose tolerance test	0.000	0.995	0.005
O23.3 Infections of other parts of urinary tract in pregnancy	0.000	0.995	0.005
O23.2 Infections of urethra in pregnancy	0.000	0.995	0.005
O23.1 Infections of bladder in pregnancy	0.000	0.995	0.005
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.000	0.995	0.005
O28.8 Other abnormal findings on antenatal screening of mother	0.000	0.995	0.005
O28.5 Abnormal chromosomal and genetic finding on antenatal screening of mother	0.000	0.995	0.005
O28.4 Abnormal radiological finding on antenatal screening of mother	0.000	0.995	0.005
O28.2 Abnormal cytological finding on antenatal screening of mother	0.000	0.995	0.005
O28.9 Abnormal finding on antenatal screening of mother, unspecified	0.000	0.995	0.005
M49.5 Collapsed vertebra in diseases classified elsewhere	0.000	0.995	0.005
O21.8 Other vomiting complicating pregnancy	0.000	0.995	0.004
O24.4 Diabetes mellitus arising in pregnancy	0.000	0.995	0.005
O24.0 Pre-existing diabetes mellitus, insulin-dependent	0.000	0.995	0.004
O22.0 Varicose veins of lower extremity in pregnancy	0.000	0.995	0.004
O28.0 Abnormal haematological finding on antenatal screening of mother	0.000	0.995	0.004
N08 Glomerular disorders in diseases classified elsewhere	0.005	0.995	0.000
O22.1 Genital varices in pregnancy	0.000	0.995	0.004
T78.2 Anaphylactic shock, unspecified	0.000	0.996	0.004
O22.9 Venous complication in pregnancy, unspecified	0.000	0.996	0.004
O22.8 Other venous complications in pregnancy	0.000	0.996	0.004
O22.5 Cerebral venous thrombosis in pregnancy	0.000	0.996	0.004
O22.2 Superficial thrombophlebitis in pregnancy	0.000	0.996	0.004
O29.9 Complication of anaesthesia during pregnancy, unspecified	0.000	0.996	0.004
O29.8 Other complications of anaesthesia during pregnancy	0.000	0.996	0.004
O29.6 Failed or difficult intubation during pregnancy	0.000	0.996	0.004
O29.5 Other complications of spinal and epidural anaesthesia during pregnancy	0.000	0.996	0.004
O29.4 Spinal and epidural anaesthesia-induced headache during pregnancy	0.000	0.996	0.004
O29.3 Toxic reaction to local anaesthesia during pregnancy	0.000	0.996	0.004
O29.2 Central nervous system complications of anaesthesia during pregnancy	0.000	0.996	0.004
O29.1 Cardiac complications of anaesthesia during pregnancy	0.000	0.996	0.004
O29.0 Pulmonary complications of anaesthesia during pregnancy	0.000	0.996	0.004
T78.4 Allergy, unspecified	0.000	0.996	0.004
F20.9 Schizophrenia, unspecified	0.000	0.996	0.004
O22.4 Haemorrhoids in pregnancy	0.000	0.996	0.004
O23.9 Other and unspecified genito-urinary tract infection in pregnancy	0.000	0.996	0.004
Q51 Congenital malformations of uterus and cervix	0.004	0.996	0.000
O22.3 Deep phlebothrombosis in pregnancy	0.000	0.996	0.004
O24.3 Pre-existing diabetes mellitus, unspecified	0.000	0.996	0.004
O24.2 Pre-existing malnutrition-related diabetes mellitus	0.000	0.996	0.004
O24.1 Pre-existing diabetes mellitus, noninsulin-dependent	0.000	0.996	0.004
T78.0 Anaphylactic shock due to adverse food reaction	0.000	0.996	0.004
O28.3 Abnormal ultrasonic finding on antenatal screening of mother	0.000	0.996	0.004
J06.8 Other acute upper respiratory infections of multiple sites	0.000	0.996	0.004
E66.8 Other obesity	0.004	0.996	0.000
T78 Adverse effects, not elsewhere classified	0.000	0.996	0.004
J06.0 Acute laryngopharyngitis	0.000	0.996	0.004
E83.3 Disorders of phosphorus metabolism	0.004	0.996	0.000
E14 Unspecified diabetes mellitus	0.003	0.996	0.001
M49.56 Collapsed vertebra in diseases classified elsewhere (Lumbar region)	0.000	0.996	0.004
K08.9 Disorder of teeth and supporting structures, unspecified	0.004	0.996	0.000
Q51.2 Other doubling of uterus	0.004	0.996	0.000
N17-N19 Renal failure	0.004	0.996	0.000
M49.50 Collapsed vertebra in diseases classified elsewhere (Multiple sites in spine)	0.000	0.996	0.004
N08.5 Glomerular disorders in systemic connective tissue disorders	0.004	0.996	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.004	0.996	0.000
F25 Schizoaffective disorders	0.000	0.996	0.004
F20 Schizophrenia	0.000	0.996	0.004
F20.5 Residual schizophrenia	0.000	0.996	0.004
O24.9 Diabetes mellitus in pregnancy, unspecified	0.000	0.996	0.004
F25.1 Schizoaffective disorder, depressive type	0.000	0.996	0.004
M11.26 Other chondrocalcinosis (Lower leg)	0.004	0.996	0.000
M49.59 Collapsed vertebra in diseases classified elsewhere (Site unspecified)	0.000	0.996	0.003
M49.58 Collapsed vertebra in diseases classified elsewhere (Sacral and sacrococcygeal region)	0.000	0.996	0.003
M49.57 Collapsed vertebra in diseases classified elsewhere (Lumbosacral region)	0.000	0.996	0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations